NewGenIvf (NIVFW) EBIT (2024 - 2025)
NewGenIvf (NIVFW) posted quarterly EBIT of -$5.0 million for Q4 2025, down 356.66% YoY from $1.9 million in Q4 2024, and down 97.95% sequentially from -$2.5 million in Q3 2025.
NewGenIvf (NIVFW) EBIT (2024 - 2025) Analysis & Trends
NewGenIvf has disclosed EBIT across 2 years of filings, most recently posting -$5.0 million for Q4 2025.
- In Q4 2025, EBIT fell 356.66% year-over-year to -$5.0 million; the TTM figure through Dec 2025 stood at -$8.4 million (changed N/A YoY), while the FY2025 annual figure was -$10.7 million, down 824.3% from the prior year.
- EBIT declined to -$5.0 million in Q4 2025, from -$2.5 million in the prior quarter.
- Over the last five years, EBIT for NIVFW reached as high as $216311.0 in Q3 2024 and fell as low as -$5.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 87.94 Bn | 90.32 Bn | 16.26 Bn | -566.00 Mn |
| 2 | Chemed | 18.08 Bn | 18.07 Bn | 215.76 Mn | 84.58 Mn |
| 3 | Tenet Healthcare | 16.59 Bn | 15.76 Bn | 4.41 Bn | 1.30 Bn |
| 4 | Davita | 15.37 Bn | 16.23 Bn | 1.07 Bn | 481.89 Mn |
| 5 | Encompass Health | 10.07 Bn | 10.70 Bn | 1.34 Bn | 59.70 Mn |
| 6 | Ensign | 9.52 Bn | 8.93 Bn | 293.37 Mn | 124.85 Mn |
| 7 | Universal Health Services | 9.19 Bn | 9.15 Bn | 3.21 Bn | 502.86 Mn |
| 8 | Pacs | 6.96 Bn | 6.72 Bn | 345.96 Mn | 120.04 Mn |
| 9 | Ww International | 6.14 Bn | 5.98 Bn | -149.29 Mn | -34.14 Mn |
| 10 | NewGenIvf | - | - | 524,025.00 | -4.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.97 Mn |
| Sep 30, 2025 | -2.51 Mn |
| Dec 31, 2024 | -1.09 Mn |
| Sep 30, 2024 | 216,311.00 |